Shafique Virani, Chief Business Officer at RECURSION PHARMACEUTICALS, INC. (RXRX), sold 20,613 shares at $12.70 ($254K) on 2022-11-15, disclosed to the SEC on 2022-11-17.
Open-market sale of $254k RXRX by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.86 | 613 | $7K | 2.9% |
| 2 | $11.92 | 4,941 | $59K | 23.2% |
| 3 | $11.92 | 4,941 | $59K | 23.2% |
| 4 | $12.70 | 5,059 | $64K | 25.3% |
| 5 | $12.70 | 5,059 | $64K | 25.3% |
| Total | $12.30 avg | 20,613 |
| $254K |
| 100% |
| Filing → |
| RXRX | SELL | 2023-11-17 | $117K | — | Filing → |
| RXRX | SELL | 2023-10-18 | $113K | — | Filing → |
| RXRX | SELL | 2023-09-19 | $156K | — | Filing → |